Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zetia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

CETP inhibitor class finally dies as Merck abandons anacetrapib

CETP inhibitor class finally dies as Merck abandons anacetrapib

Some have argued that the company should file given its big investment in the project and established commercial infrastructure, which succeeded in turning another cholesterol-lowering drug with lacklustre data - Zetia

Merck & Co's anacetrapib data fails to generate much excitement

Merck & Co's anacetrapib data fails to generate much excitement selling Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin) in this therapeutic area despite a small effect on cardiovascular outcomes.

First round to Amgen in PCSK9 patent battle with Sanofi

First round to Amgen in PCSK9 patent battle with Sanofi For example, some payers are insisting that patients on statins try adding Merck &Co's selective cholesterol-absorption inhibitor Zetia (ezetimibe) before moving on to a PCSK9 inhibitor.

NICE backs Repatha but rejects cholesterol rival Praluent

NICE backs Repatha but rejects cholesterol rival Praluent Specifically, the UK watchdog said it was concerned that unlike Repatha Praluent has not been compared to the existing combination therapy of a statin plus MSD's Zetia (ezetimibe) in clinical

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics